Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

DEA Responds to Hospital Concerns, Clarifies Regulation on Disposal of Controlled Substances

October 31, 2014—The Drug Enforcement Administration (DEA) in an Oct. 17 letter addressed a series of concerns raised by the hospital community regarding the disposal of pharmaceutical waste. The concerns were outlined in an Oct. 6 group letter signed by the AAMC and eight other hospital associations and sent to DEA Administrator Michele Leonhart [see Washington Highlights, Oct. 10].

The Oct. 6 letter explained that hospital-related requirements established under the Oct. 9 DEA final rule on the Disposal of Controlled Substances jeopardized patient and employee safety, likely could not be completed on-site, and presented significant administrative challenges.

In its Oct. 17 response, the DEA distinguishes between “inventory” and “wastage” and clarifies that the final rule was intended to address the disposal of unwanted controlled substances from a provider’s inventory, and not the small amounts left over after the treatment of a patient (i.e., wastage).

Contact:

Christiane Mitchell
Senior Director Health Care Affairs
Telephone: 202-828-0461
Email: cmitchell@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org